five

Expression changes in BRCA1-deficient breast cancer PDX models treated with PARP-inhibitors.

收藏
NIAID Data Ecosystem2026-03-10 收录
下载链接:
https://www.ncbi.nlm.nih.gov/sra/ERP108822
下载链接
链接失效反馈
官方服务:
资源简介:
BRCA1 deficiencies cause breast, ovarian and other cancers, and render tumours hypersensitive to PARP-inhibitors. To understand resistance mechanisms, we conducted explored expression changes in BRCA1-deficient breast cancer PDX models treated with PARP-inhibitors.
创建时间:
2018-07-04
二维码
社区交流群
二维码
科研交流群
商业服务